PharmaShots | Incisive News in 3 Shots

Subscribe Now

Post-Transplant CMV Infection

Takeda Reports the US FDA's Acceptance and Priority Review of Maribavir's NDA for Post-Transplant CMV Infection

Takeda Reports the US FDA's Acceptance and Priority Review of Maribavir's NDA for Post-Transplant CMV Infection

May 21, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us